Revolution Medicines’ pan-RAS inhibitor helped patients with a highly aggressive form of pancreatic cancer live an average of six months longer than chemotherapy, hitting a goal of the phase 3 study.

As the anticipation of golf’s first major tournament crescendoes, our attention focuses on all things Masters at Augusta National. While bentgrass greens are trimmed to precision and pink azaleas ...